BACKGROUND: Children with bipolar disorder (BD) or severe mood dysregulation (SMD) show behavioural and neural deficits during facial emotion processing. In those with other psychiatric disorders, such deficits have been associated with reduced attention to eye regions while looking at faces. METHODS: We examined gaze fixation patterns during a facial emotion labelling task among children with pediatric BD and SMD and among healthy controls. Participants viewed facial expressions with varying emotions (anger, fear, sadness, happiness, neutral) and emotional levels (60%, 80%, 100%) and labelled emotional expressions. RESULTS: Our study included 22 children with BD, 28 with SMD and 22 controls. Across all facial emotions, children with BD and SMD made more labelling errors than controls. Compared with controls, children with BD spent less time looking at eyes and made fewer eye fixations across emotional expressions. Gaze patterns in children with SMD tended to fall between those of children with BD and controls, although they did not differ significantly from either of these groups on most measures. Decreased fixations to eyes correlated with lower labelling accuracy in children with BD, but not in those with SMD or in controls. LIMITATIONS: Most children with BD were medicated, which precluded our ability to evaluate medication effects on gaze patterns. CONCLUSION: Facial emotion labelling deficits in children with BD are associated with impaired attention to eyes. Future research should examine whether impaired attention to eyes is associated with neural dysfunction. Eye gaze deficits in children with BD during facial emotion labelling may also have treatment implications. Finally, children with SMD exhibited decreased attention to eyes to a lesser extent than those with BD, and these equivocal findings are worthy of further study.
BACKGROUND:Children with bipolar disorder (BD) or severe mood dysregulation (SMD) show behavioural and neural deficits during facial emotion processing. In those with other psychiatric disorders, such deficits have been associated with reduced attention to eye regions while looking at faces. METHODS: We examined gaze fixation patterns during a facial emotion labelling task among children with pediatric BD and SMD and among healthy controls. Participants viewed facial expressions with varying emotions (anger, fear, sadness, happiness, neutral) and emotional levels (60%, 80%, 100%) and labelled emotional expressions. RESULTS: Our study included 22 children with BD, 28 with SMD and 22 controls. Across all facial emotions, children with BD and SMD made more labelling errors than controls. Compared with controls, children with BD spent less time looking at eyes and made fewer eye fixations across emotional expressions. Gaze patterns in children with SMD tended to fall between those of children with BD and controls, although they did not differ significantly from either of these groups on most measures. Decreased fixations to eyes correlated with lower labelling accuracy in children with BD, but not in those with SMD or in controls. LIMITATIONS: Most children with BD were medicated, which precluded our ability to evaluate medication effects on gaze patterns. CONCLUSION:Facial emotion labelling deficits in children with BD are associated with impaired attention to eyes. Future research should examine whether impaired attention to eyes is associated with neural dysfunction. Eye gaze deficits in children with BD during facial emotion labelling may also have treatment implications. Finally, children with SMD exhibited decreased attention to eyes to a lesser extent than those with BD, and these equivocal findings are worthy of further study.
Authors: H Critchley; E Daly; M Phillips; M Brammer; E Bullmore; S Williams; T Van Amelsvoort; D Robertson; A David; D Murphy Journal: Hum Brain Mapp Date: 2000-02 Impact factor: 5.038
Authors: Amanda E Guyer; Erin B McClure; Abby D Adler; Melissa A Brotman; Brendan A Rich; Alane S Kimes; Daniel S Pine; Monique Ernst; Ellen Leibenluft Journal: J Child Psychol Psychiatry Date: 2007-09 Impact factor: 8.982
Authors: J Uekermann; M Kraemer; M Abdel-Hamid; B G Schimmelmann; J Hebebrand; I Daum; J Wiltfang; B Kis Journal: Neurosci Biobehav Rev Date: 2009-10-24 Impact factor: 8.989
Authors: Tomer Levy; Annie Dupuis; Brendan F Andrade; Jennifer Crosbie; Elizabeth Kelley; Rob Nicolson; Russell James Schachar Journal: Eur Child Adolesc Psychiatry Date: 2022-09-01 Impact factor: 5.349
Authors: M A Brotman; W-L Tseng; A K Olsavsky; S J Fromm; E J Muhrer; J G Rutenberg; C M Deveney; N E Adleman; C A Zarate; D S Pine; E Leibenluft Journal: Psychol Med Date: 2013-08-12 Impact factor: 7.723